Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
WYETH AND AYERST TO MERGE UNDER LEADERSHIP OF WYETH's CANAVAN; NEW WYETH-AYERST LABS WILL HAVE SALES OF $2.5 MIL. AND SALES FORCE OF 1,750
Aug 31 1987
•
By
The Pink Sheet
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Archive
More from Pink Sheet